Study finds new immunotherapy matches standard treatment for esophageal cancer survival
Disease control
Completed
This study looked back at 203 patients with advanced esophageal cancer to compare two different pre-surgery treatment approaches. One group received immunotherapy combined with chemotherapy, while the other received the standard treatment of chemotherapy plus radiation. The resea…
Phase: NA • Sponsor: Yongtao Han • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC